These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 1315881)

  • 1. [Apheresis for demyelinating diseases].
    Matsunaga M; Sato T
    Nihon Rinsho; 1992 Jan; 50 Suppl():345-50. PubMed ID: 1315881
    [No Abstract]   [Full Text] [Related]  

  • 2. Plasmapheresis, lymphocytapheresis, and immunosuppressive drug therapy in multiple sclerosis.
    Hauser SL; Fosburg M; Kevy S; Weiner HL
    Prog Clin Biol Res; 1982; 106():239-54. PubMed ID: 6184727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunological treatment of multiple sclerosis. II.
    Hughes RA
    J Neurol; 1986 Apr; 233(2):66-8. PubMed ID: 3009722
    [No Abstract]   [Full Text] [Related]  

  • 4. Intensive immunosuppression in progressive multiple sclerosis. A randomized, three-arm study of high-dose intravenous cyclophosphamide, plasma exchange, and ACTH.
    Hauser SL; Dawson DM; Lehrich JR; Beal MF; Kevy SV; Propper RD; Mills JA; Weiner HL
    N Engl J Med; 1983 Jan; 308(4):173-80. PubMed ID: 6294517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cyclophosphamide in the therapy of multiple sclerosis].
    Salvatores U; Majeron M; Mascetti A
    Riv Sper Freniatr Med Leg Alien Ment; 1972 Feb; 96(1):163-84. PubMed ID: 4337775
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical spectrum of multiple sclerosis.
    Reder AT; Antel JP
    Neurol Clin; 1983 Aug; 1(3):573-99. PubMed ID: 6095009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunosuppression in progressive multiple sclerosis with high dose intravenous cyclophosphamide and monoclonal antibodies.
    Dawson DM; Carter JL; Hafler DA; Weiner HL
    Riv Neurol; 1987; 57(2):88-91. PubMed ID: 3039645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunosuppressive treatment im multiple sclerosis].
    Mertin J
    Fortschr Med; 1980 Oct; 98(37):1431-6. PubMed ID: 6253370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A period of trial in American apheresis medicine.
    Weinstein R
    Transfus Apher Sci; 2001 Oct; 25(2):89-91. PubMed ID: 11761279
    [No Abstract]   [Full Text] [Related]  

  • 10. Multiple sclerosis: pilot therapeutic trial of immunosuppressants.
    Cendrowski WS
    Schweiz Arch Neurol Neurochir Psychiatr; 1969; 105(2):241-6. PubMed ID: 4314087
    [No Abstract]   [Full Text] [Related]  

  • 11. Double-blind study of true vs. sham plasmapheresis in patients being treated with immunosuppression for acute attacks of multiple sclerosis.
    Weiner HL; Dau PC; Khatri BO; Petajan J; Birnbaum G; McQuillen MP; Fosburg MT; Feldstein M; Orav J
    Prog Clin Biol Res; 1990; 337():283. PubMed ID: 2162062
    [No Abstract]   [Full Text] [Related]  

  • 12. [Multiple sclerosis].
    Tanosaki M; Matsunaga M
    Nihon Rinsho; 2004 May; 62 Suppl 5():586-9. PubMed ID: 15197989
    [No Abstract]   [Full Text] [Related]  

  • 13. The evidence justifying immunosuppression therapy in multiple sclerosis.
    Mertin J
    Proc R Soc Med; 1977 Dec; 70(12):871-4. PubMed ID: 202967
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment and prevention of myelin disorders: multiple sclerosis.
    Abramsky O
    Bull Soc Belge Ophtalmol; 1983 Nov; 208 Pt 1():489-92. PubMed ID: 6326915
    [No Abstract]   [Full Text] [Related]  

  • 15. Cyclophosphamide and plasma exchange in multiple sclerosis.
    Lancet; 1991 Apr; 337(8748):1033-4. PubMed ID: 1673181
    [No Abstract]   [Full Text] [Related]  

  • 16. Plasma exchange for MS.
    Noseworthy JH; Vandervoort MK; Ebers GC
    Neurology; 1990 May; 40(5):864-6. PubMed ID: 2158638
    [No Abstract]   [Full Text] [Related]  

  • 17. [Therapeutic plasma exchange for neuroimmunological disorders].
    Shibuya N
    No To Shinkei; 1993 Oct; 45(10):925-32. PubMed ID: 8268032
    [No Abstract]   [Full Text] [Related]  

  • 18. Cyclophosphamide and plasma exchange in multiple sclerosis.
    Noseworthy JH; Vandervoort MK; Penman M; Ebers G; Shumak K; Seland TP; Roberts R; Yetisir E; Gent M; Taylor DW
    Lancet; 1991 Jun; 337(8756):1540-1. PubMed ID: 1675382
    [No Abstract]   [Full Text] [Related]  

  • 19. Controlled trial of plasma exchange and leukapheresis in polymyositis and dermatomyositis.
    Miller FW; Leitman SF; Cronin ME; Hicks JE; Leff RL; Wesley R; Fraser DD; Dalakas M; Plotz PH
    N Engl J Med; 1992 May; 326(21):1380-4. PubMed ID: 1472183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [ACTH treatment of multiple sclerosis].
    Boman K; Hokkanen E; Jarho L; Kivalo E
    Duodecim; 1966; 82(18):867-73. PubMed ID: 4288673
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.